A study published in Nature Cancer details how OCRA-funded research has dramatically expanded the impact of DNA and RNA data in the Cancer Genome Atlas and Cancer Cell Line Encyclopedia, by analyzing samples for protein expression related to cancer.
The research team behind the study includes Dr. Gordon Mills, an Ovarian Cancer Research Alliance grantee who was awarded OCRA’s Collaborative Research Development Grant in 2018.
A research team, led by Dr. Ugo Cavallaro and supported by OCRA’s 2019 Collaborative Research Development Grant, made progress toward improving immunotherapies for ovarian cancer. Dr. Frances R. Balkwill, a … Continued
Leaders in the patient advocacy space came together for a wide-ranging study on the often-overlooked challenges faced by caregivers of cancer patients, with Tracy Moore, LCSW, who serves as Ovarian … Continued
Record number of applications received Ovarian Cancer Research Alliance (OCRA) announced today that it will invest more than $6 million in research initiatives in 2025, which includes promising projects targeting … Continued
Get email updates about research news, action alerts, and ways to join the fight.
